Blockade of DNA methylation enhances the therapeutic effect of gefitinib in non-small cell lung cancer cells

By Li Xiao-You   Wu Jian-Zhong   Cao Hai-Xia   Ma Rong   Wu Jian-Qiu   Zhong Yue-Jiao   Feng Ji-Feng  

Oncology Reports, Vol. 29, Iss. 5, 2013-05 ,pp. : 1975-1982

Spandidos Publications

Access to resources Recommend Favorite

Predictors of outcome for EGFR-mutant non-small-cell lung cancer treated with first-line tyrosine kinase inhibitors

By Pilotto Sara   Bria Emilio  

Lung Cancer Management, Vol. 2, Iss. 2, 2013-04 ,pp. : 89-92

Future Medicine

Access to resources Recommend Favorite

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 931-938

Spandidos Publications

Access to resources Recommend Favorite

Integrin β1mediated acquired gefitinib resistance in nonsmall cell lung cancer cells occurs via the phosphoinositide 3-kinasedependent pathway

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 535-542

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

By                          

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1430-1436

Spandidos Publications

Access to resources Recommend Favorite